Need professional-grade analysis? Visit stockanalysis.com
$3.82B
15.48
4,703
N/A
Price Chart
Also Listed On
Covista Inc. (CVSA) Price Performance
Covista Inc. (CVSA) trades on United States in USD. The company is classified in the Consumer Defensive sector under the Education & Training Services industry. The stock currently trades at $113.08, up 6.19% from the previous close.
Over the past year, CVSA has traded between a low of $96.07 and a high of $113.08. The stock has gained 13.5% over this period. It is currently 17.7% above its 52-week low.
Covista Inc. has a market capitalization of $3.82B, with a price-to-earnings ratio of 15.48.
About Covista Inc.
Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company offers degree and non-degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.
Company Info
- Sector
- Consumer Defensive
- Industry
- Education & Training Services
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- $1.45B
- EBITDA
- $428.91M
- Profit Margin
- 13.41%
- EPS (TTM)
- 2.36
- Book Value
- 39.79
Technical Indicators
- 52 Week High
- $114.38
- 52 Week Low
- $94.11
- 50 Day MA
- $105.74
- 200 Day MA
- $118.04
- Beta
- 0.73
Valuation
- Trailing P/E
- 15.48
- Forward P/E
- 11.95
- Price/Sales
- 2.02
- Price/Book
- 2.63
- Enterprise Value
- $4.97B